VEITHsymposium™

Program (November 2022)

The program features over 1,300 rapid-fire presentations offered in more than 100 sessions throughout the five-day event. Click on the day below to review the sessions, then click on the session number to see a listing of presentations and speakers within a session.

View/Search/Print Complete 2022 Program Brochure in PDF
View/Print Entire November 2022 Program

Program Outline at a Glance

TUESDAY PROGRAMS
Program A:	(Sessions 1-8) 6:45 A.M. – 6:02 P.M. (10.25 CME CREDIT HOURS) PROGRESS IN THE TREATMENT OF DISEASES OF THE CORONARY ARTERIES, HEART VALVES AND THE THORACIC AND ABDOMINAL AORTA
Location:	GRAND BALLROOM EAST, 3RD FLOOR

Program B:	(Sessions 9-16) 6:44 A.M. – 6:05 P.M. (10 CME CREDIT HOURS) PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY, SIMULATION AND COVID; NEW DEVELOPMENTS IN CAROTID DISEASE AND ACUTE STROKE TREATMENT; ABDOMINAL AORTIC BRANCH TREATMENT; NEW TECHNOLOGY CONCEPTS AND ARTIFICIAL INTELLIGENCE (AI); VASCULAR SURGERY IDENTITY, TRAINING, MANPOWER AND MENTORSHIP; UPDATES ON OPEN AND HYBRID VASCULAR SURGERY AND TREATMENT OF AORTIC COARCTATION
Location:	GRAND BALLROOM WEST, 3RD FLOOR

Program C-1:	(Sessions 17-18) 7:00 A.M. – 12:00 P.M. (4.5 CME CREDIT HOURS) MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH
Location:	TRIANON BALLROOM, 3RD FLOOR

Program C-2:	(Sessions 19-22) 1:00 P.M. – 6:00 P.M. (5 CME CREDIT HOURS) INTERESTING TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
Location:	TRIANON BALLROOM, 3RD FLOOR

WEDNESDAY PROGRAMS
Program D:	(Sessions 23-30) 6:40 A.M. – 6:02 P.M. (10.25 CME CREDIT HOURS) PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT
Location:	GRAND BALLROOM EAST, 3RD FLOOR

Program E:	(Sessions 31-38) 6:40 A.M. – 6:05 P.M. (10.25 CME CREDIT HOURS) NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTI-ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; MANAGEMENT OF ENDOLEAKS; RECORDED LIVE CASES FROM LEADING CENTERS IN THE US AND EU; ISSUES OF INTEREST; OUTPATIENT AND OFFICE BASED VASCULAR TREATMENT; TOPICS RELATED TO GOVERNMENT, REIMBURSEMENT, THE SVS, VQI, FDA, GUIDELINES, TRIALS AND EVIDENCE BASED MEDICINE
Location:	GRAND BALLROOM WEST, 3RD FLOOR

Program F:	(Sessions 39-46) 6:50 A.M. – 6:10 P.M. (10 CME CREDIT HOURS) MORE NEW DEVELOPMENTS IN THORACIC AORTIC DISEASE, TEVAR, AORTIC DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER BARE STENTS, INFRARENAL AAAs AND STANDARD EVAR, AND HOT NEW AORTIC AND CAROTID TOPICS
Location:	TRIANON BALLROOM, 3RD FLOOR

THURSDAY PROGRAMS
Program G:	(Sessions 47-54) 6:50 A.M. – 6:07 P.M. (10 CME CREDIT HOURS) EXCITING NEW OR REDISCOVERED TECHNIQUES, CONCEPTS OR DEVICES; PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; PROGRESS IN THE TREATMENT OF RUPTURED AAAs; MORE ABOUT NEW DEVICES, TECHNIQUES OR CONCEPTS; PROGRESS IN RADIATION SAFETY
Location:	GRAND BALLROOM EAST, 3RD FLOOR

Program H:	(Sessions 55-63) 6:50 A.M. – 5:52 P.M. (9.75 CME CREDIT HOURS) NEW OR IMPROVED DEVICES FOR: STANDARD EVAR, EVAS AND MORE COMPLEX AAAs; REPAIRS OF TAAAs, THE ASCENDING AORTA, THE AORTIC ARCH, AND THE DESCENDING AORTA (TEVAR); NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDO OR OPEN TECHNIQUES; UPDATE ON ENDOANCHORS AND FIXATION DEVICES AND NEW OR IMPROVED DEVICES FOR ENDOVASCULARLY REMOVING CLOT AND OCCLUDING BLOOD VESSELS
Location:	GRAND BALLROOM WEST, 3RD FLOOR

Program I:	(Sessions 64-71) 7:00 A.M. – 6:25 P.M. (11 CME CREDIT HOURS) SUPERFICIAL VENOUS DISEASE
Location:	TRIANON BALLROOM, 3RD FLOOR

Program J:	(Sessions 72-75) 8:00 A.M. – 12:15 P.M. (4.25 CME CREDIT HOURS TBD) MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT
Location:	MURRAY HILL SUITES, 2ND FLOOR

FRIDAY PROGRAMS
Program K:	(Sessions 76-83) 6:50 A.M. – 6:02 P.M. (10 CME CREDIT HOURS) PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) WITH TAAAs AND COMPLEX AORTIC ANEURYSM REPAIRS; NEW DEVELOPMENTS IN CAROTID ARTERY DISEASE AND ITS TREATMENT: MESH COVERED STENTS AND TCAR, COGNITIVE CHANGES, TIMING OF TREATMENT, MEDICAL TREATMENT, UPDATE ON CAROTID TRIALS, TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS), STRING SIGN, CAROTID CLOT, SIGNIFICANCE OF MRI LESIONS, CAROTID CONTROVERSIES AND MORE CAROTID TOPICS; OTHER NEW ENDOVASCULAR TREATMENT CONCEPTS, TECHNIQUES; UPDATE ON PERCUTANEOUS ACCESS CLOSURE DEVICES AND WOUND CARE
Location:	GRAND BALLROOM EAST, 3RD FLOOR

Program L:	(Sessions 84-91) 7:00 A.M. – 5:42 P.M. (9.5 CME CREDIT HOURS) NEW DEVELOPMENTS IN THE TREATMENT OF POPLITEAL DISEASE: ANEURYSMS, ENTRAPMENT AND OCCLUSIVE LESIONS; ADVANCES IN TREATING ARTERIAL AND GRAFT INFECTIONS; ADVANCES IN VASCULAR IMAGING AND GUIDANCE; AUGMENTED REALITY AND ARTIFICIAL INTELLIGENCE; RECORDED LIVE COMPLEX ENDOVASCULAR CASES FROM MÜNSTER, GERMANY; NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME MANAGEMENT; ADVANCES IN MEDICAL, DRUG, ANTICOAGULANT AND RARE VASCULAR DISEASE TREATMENT; AND ADVANCES IN THE TREATMENT OF VASCULAR TRAUMA
Location:	GRAND BALLROOM WEST, 3RD FLOOR

Program M:	(Sessions 92-101) 6:30 A.M. – 4:57 P.M. (10.25 CME CREDIT HOURS) DEEP VENOUS DISEASE
Location:	TRIANON BALLROOM, 3RD FLOOR

SATURDAY PROGRAMS
Program N:	(Sessions 102-106) 6:55 A.M. – 1:30 P.M. (6.25 CME CREDIT HOURS) TOPICS TOO IMPORTANT TO MISS IN THE TREATMENT OF LOWER EXTREMITY, AORTIC OR CAROTID DISEASE
Location:	GRAND BALLROOM EAST, 3RD FLOOR

Program O:	(Sessions 107-112) 8:00 A.M. – 4:05 P.M. (6.75 CME CREDIT HOURS) IMPROVING OUTCOMES IN HEMODIALYSIS ACCESS
Location:	GRAND BALLROOM WEST, 3RD FLOOR

Tuesday, November 15, 2022 - Program Details

Open All Tuesday Sessions

COMBINED PROGRAM FOR VASCULAR SURGERY, INTERVENTIONAL RADIOLOGY, CARDIOLOGY AND CARDIOTHORACIC SURGERY

6:00 AM - General Registration - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor

PROGRAMS A, B AND C ARE CONCURRENT TUESDAY PROGRAMS
PROGRAM A (SESSIONS 1-8 - PROGRESS IN THE TREATMENT OF DISEASES OF THE CORONARY ARTERIES, HEART VALVES AND THE THORACIC AND ABDOMINAL AORTA; 6:45 A.M. to 6:02 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 1:	PROGRESS IN CORONARY ARTERY STENTING, TRANSCATHETER VALVE REPLACEMENT, AND TREATMENT OF ASCENDING AORTIC DISEASE
SESSION 2:	PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
SESSION 3:	PROGRESS IN THE ENDOVASCULAR TREATMENT OF AORTIC DISSECTIONS: REPORTING STANDARDS, CLASSIFICATION SYSTEMS, STABILISE, AND MORE
SESSION 4:	MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
SESSION 5:	NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY AND TREATMENT, EVAR AND EVAS (ENDOVASCULAR ANEURYSM SEALING) (5 And 4 ¾-MINUTE [SS] TALKS)
SESSION 6:	MORE ABOUT AAAs AND EVAR: UPDATES ON THE UK NICE AAA GUIDELINES AND SACCULAR AAAs
SESSION 7:	MORE NEW DEVELOPMENTS IN THE TREATMENT OF AORTIC DISSECTIONS AND THORACIC PATHOLOGY; STROKE PREVENTION WITH TEVAR
SESSION 8:	MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NATURAL HISTORY; NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TBADs
PROGRAM B (SESSIONS 9-16 - PROGRESS IN VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY, SIMULATION AND COVID; NEW DEVELOPMENTS IN CAROTID DISEASE AND ACUTE STROKE TREATMENT; ABDOMINAL AORTIC BRANCH TREATMENT; NEW TECHNOLOGY CONCEPTS AND ARTIFICIAL INTELLIGENCE (AI); VASCULAR SURGERY IDENTITY, TRAINING, MANPOWER AND MENTORSHIP; UPDATES ON OPEN AND HYBRID VASCULAR SURGERY AND TREATMENT OF AORTIC COARCTATION; 6:44 A.M. to 6:05 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 9:	PROGRESS IN VASCULAR ROBOTICS, LAPAROSCOPY, GUIDANCE SYSTEMS AND SIMULATION
SESSION 10:	NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
SESSION 11:	MORE ABOUT CAROTID AND VERTEBRAL DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
SESSION 12:	PROGRESS IN THE TREATMENT OF AORTIC AND AORTO-ILIAC OCCLUSIVE DISEASE
SESSION 13:	NEW CONCEPTS, MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI) (See also Session 87)
SESSION 14:	PART 1: VASCULAR SURGERY’S NUMBERS AND IDENTITY AND HOW TO MEET THE SPECIALTY’S NEEDS FOR ITS SERVICES; THE IMPORTANCE OF MENTORSHIP IN VASCULAR SURGERY PART 2: LATE BREAKING DEVELOPMENTS IN COVID RELATED VASCULAR DISEASE ISSUES
SESSION 15:	PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE
SESSION 16:	UPDATE ON OPEN VASCULAR SURGICAL AND HYBRID PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS
PROGRAM C-1 (SESSIONS 17-18 - MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE TEAM APPROACH; 7:00 A.M. to 12:00 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 17:	MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 1
SESSION 18:	MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
PROGRAM C-2 (SESSIONS 19-22 - INTERESTING TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS; 1:00 P.M. to 6:00 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 19:	HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
SESSION 20:	MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT
SESSION 21:	HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE (ALL TALKS ARE 4 ¾ MINUTES)
SESSION 22:	MORE HOT NEW SHORT SUMMARY TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND CHRONIC LIMB THREATENING ISCHEMIA (CLTI) [ALL TALKS ARE 4 ¾ MINUTES]

Wednesday, November 16, 2022 - Program Details

Open All Wednesday Sessions

PROGRAMS D, E AND F ARE CONCURRENT WEDNESDAY PROGRAMS
PROGRAM D (SESSIONS 23-30 - PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT 6:40 A.M. to 6:02 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 23:	GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI (5 AND 4 ¾-MINUTE SHORT SUMMARY [SS] TALKS)
SESSION 24:	NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE) [ALL TALKS ARE 5 MINUTES]
SESSION 25:	LOWER EXTREMITY TOPICS RELATED TO THE DRUG COATED DEVICES CAUSING INCREASED MORTALITY CONTROVERSY: DO PACLITAXEL COATED DEVICES CAUSE INCREASED MORTALITY: DEB AND DES ALTERNATIVES TO PACLITAXEL AND RELATED ISSUES
SESSION 26:	NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
SESSION 27:	PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: HOW TO SAVE THE “NO OPTION FOR TREATMENT” LIMB OR THE “DESERT FOOT” WITH NO PATENT TARGET ARTERIES
SESSION 28:	NEW DEVELOPMENTS IN STENTS; PROSTHETIC GRAFTS; ENDOVASCULAR BYPASSES; STENT GRAFTS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
SESSION 29:	LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
SESSION 30:	NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION AND ACUTE LIMB ISCHEMIA
PROGRAM E (SESSIONS 31-38 - NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTI- ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; MANAGEMENT OF ENDOLEAKS; RECORDED LIVE CASES FROM LEADING CENTERS IN THE US AND EU; ISSUES OF INTEREST; OUTPATIENT AND OFFICE BASED VASCULAR TREATMENT; TOPICS RELATED TO GOVERNMENT, REIMBURSEMENT, THE SVS, VQI, FDA, GUIDELINES, TRIALS AND EVIDENCE BASED MEDICINE; 6:40 A.M. to 6:05 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 31:	ADVANCES IN MEDICAL TREATMENTS, NEW ANTI-ATHEROGENIC DRUGS, VALUE OF RIVAROXABAN AND PREVENTING MIs IN VASCULAR SURGERY PATIENTS
SESSION 32:	CATHETER BASED TREATMENTS OF RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; MORTALITY RISK IN STROKE PATIENTS; VASCULAR AND CARDIAC COMPLICATIONS OF COVID-19
SESSION 33:	PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM
SESSION 34:	TCT AND PLINIO ROSSI RECORDED LIVE COMPLEX AND CHALLENGING ENDOVASCULAR CASES
SESSION 35:	RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE LINC GROUP
SESSION 36:	ISSUES IMPORTANT IN VASCULAR SURGERY: LEADERSHIP, HISTORY, EFFICIENCY, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
SESSION 37:	MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
SESSION 38:	UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; ETHICS OF FDA ACCESS; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES, ENDPOINTS; INDUSTRY RELATIONS; IMPACT OF GOVERNMENT (ACA) AND REGULATORY AGENCIES (FDA)
PROGRAM F (SESSIONS 39-46 - MORE NEW DEVELOPMENTS IN THORACIC AORTIC DISEASE, TEVAR, AORTIC DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER BARE STENTS, INFRARENAL AAAs AND STANDARD EVAR, AND HOT NEW AORTIC AND CAROTID TOPICS; 6:50 A.M. to 6:10 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 39:	MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs), PENETRATING AORTIC ULCERS (PAUs) AND THEIR TREATMENT
SESSION 40:	MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS AND THEIR TREATMENT
SESSION 41:	OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; NEW DEVICES FOR THEIR TREATMENT
SESSION 42:	PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
SESSION 43:	MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; LINK TO CANCER; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
SESSION 44:	MORE NEW DEVELOPMENTS IN AAAs: HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR AND EVAS; OTHER RELATED AAA TOPICS
SESSION 45:	SHORT HOT AORTIC TOPICS (4 ¾-MINUTE FAST PACED TALKS
SESSION 46:	MORE SHORT HOT NEW TOPICS RELATED TO AORTO-ILIAC AND CAROTID DISEASE AND THEIR TREATMENTS (4 ¾-MINUTE FAST PACED TALKS)

Thursday, November 17, 2022 - Program Details

Open All Thursday Sessions

PROGRAMS G, H AND I AND J ARE CONCURRENT THURSDAY PROGRAMS
PROGRAM G (SESSIONS 47-54 - EXCITING NEW OR REDISCOVERED TECHNIQUES, CONCEPTS OR DEVICES; PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; PROGRESS IN THE TREATMENT OF RUPTURED AAAs; MORE ABOUT NEW DEVICES, TECHNIQUES OR CONCEPTS; PROGRESS IN RADIATION SAFETY; 6:50 A.M. to 6:07 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 47:	EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES OR CONCEPTS
SESSION 48:	PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 49:	MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 50:	A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; INNOVATIVE TECHNOLOGIES SUPPORTED BY THE DEFENSE DEPARTMENT
SESSION 51:	PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
SESSION 52:	MORE NEW DEVELOPMENTS IN RUPTURED AAAs AND TAAAs; WHAT IS AND WHAT SHOULD BE HAPPENING WITH AAA SCREENING
SESSION 53:	EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
SESSION 54:	PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
PROGRAM H (SESSIONS 55-63 - NEW OR IMPROVED DEVICES FOR: STANDARD EVAR, EVAS AND MORE COMPLEX AAAs; REPAIRS OF TAAAs, THE ASCENDING AORTA, THE AORTIC ARCH, AND THE DESCENDING AORTA (TEVAR); NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDO OR OPEN TECHNIQUES; UPDATE ON ENDOANCHORS AND FIXATION DEVICES AND NEW OR IMPROVED DEVICES FOR ENDOVASCULARLY REMOVING CLOT AND OCCLUDING BLOOD VESSELS; 6:50 A.M. to 5:52 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 55:	NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR (5-MINUTE TALKS)
SESSION 56:	NEW OR UPDATED DEVICES FOR STANDARD EVAR, EVAS (ENDOVASCULAR ANEURYSM SEALING) AND F/EVAR
SESSION 57:	NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH
SESSION 58:	NEW OR IMPROVED DEVICES FOR THORACIC AORTIC LESION REPAIRS WITH TEVAR, AND FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS (ALL TALKS ARE 4 ¾-MINUTES)
SESSION 59:	NEW OR UPDATED INFORMATION ON MRI SAFETY WITH COVERED STENTS, A NEW EMBOLIC AGENT FOR BLEEDING, LOWER EXTREMITY PROSTHETIC GRAFTS, PERIGRAFT SEROMA AND VALUE OF A PROSTHETIC PERIGRAFT SIROLIMUS PATCH (SEE ALSO SESSION 28)
SESSION 60:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, TACKS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
SESSION 61:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOONS
SESSION 62:	NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
SESSION 63:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
PROGRAM I (SESSIONS 64-71 - SUPERFICIAL VENOUS DISEASE; 7:00 A.M. to 6:25 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 64:	VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
SESSION 65:	VENOUS AND LYMPHATIC, IMAGING, AND BIOLOGY
SESSION 66:	SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
SESSION 67:	TRUNCAL ABLATION OF THE SAPHENOUS VENOUS SYSTEM
SESSION 68:	SPIDER VEINS, TRUNCAL VEINS, TRIBUTARY VEINS, PELVIC VEIN TREATMENT
SESSION 69:	VENOUS SOCIETAL AND GOVERNANCE
SESSION 70:	MORE SUPERFICIAL VEIN TREATMENT STRATEGIES AND TECHNIQUES
SESSION 71:	VENOUS CLINICAL TRIALS, LYMPHATIC, VEIN TREATMENT STRATEGIES
PROGRAM J (SESSIONS 72-75 - MULTIDISCIPLINARY ACUTE STROKE MANAGEMENT; 8:00 A.M. to 12:15 P.M.) Location: Murray Hill Suites, 2nd Floor
SESSION 72:	EMERGING TRENDS IN ISCHEMIC STROKE TREATMENT
SESSION 73:	EMERGING TRENDS IN HEMORRHAGIC STROKE TREATMENT
SESSION 74:	LATEST TRENDS IN NEUROINTERVENTIONAL SURGERY
SESSION 75:	CAROTID ARTERY LATEST TRENDS

Friday, November 18, 2022 - Program Details

Open All Friday Sessions

PROGRAMS K, L AND M ARE CONCURRENT FRIDAY PROGRAMS
PROGRAM K (SESSIONS 76-83 - PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) WITH TAAAs AND COMPLEX AORTIC ANEURYSM REPAIRS; NEW DEVELOPMENTS IN CAROTID ARTERY DISEASE AND ITS TREATMENT: MESH COVERED STENTS AND TCAR, COGNITIVE CHANGES, TIMING OF TREATMENT, MEDICAL TREATMENT, UPDATE ON CAROTID TRIALS, TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS), STRING SIGN, CAROTID CLOT, SIGNIFICANCE OF MRI LESIONS, CAROTID CONTROVERSIES AND MORE CAROTID TOPICS; OTHER NEW ENDOVASCULAR TREATMENT CONCEPTS, TECHNIQUES; UPDATE ON PERCUTANEOUS ACCESS CLOSURE DEVICES AND WOUND CARE; 6:40 A.M. to 6:02 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 76:	PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
SESSION 77:	NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
SESSION 78:	MORE CAROTID HOT TOPICS RELATED TO TCAR, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS AND COGNITIVE FUNCTION
SESSION 79:	MORE CAROTID NEW DEVELOPMENT TOPICS RELATED TO TCAR, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
SESSION 80:	MORE HOT CAROTID TOPICS: UPDATES ON KEY CAROTID RCTs; NEW INFORMATION ON TREATMENT OF TANDEM LESIONS, CAROTID ANEURYSMS AND STROKES DURING INTERVENTION
SESSION 81:	MORE HOT CAROTID TOPICS: TREATMENT IN 2022 OF PATCH INFECTIONS, STRING SIGN, CAROTID DISSECTIONS; MANAGEMENT OF ARTERIAL INJURIES DURING CENTRAL VENOUS CATHETERIZATION; OPTIMAL PLATELET AND PROTAMINE STRATEGIES; BENIGNANCY OF ACS; VALUE OF LOCAL ANESTHESIA; STROKE RISK WITH ACS PLAQUES - A WAY TO PREDICT HIGH RISK PLAQUES
SESSION 82:	NEW OR UPDATED CONCEPTS FOR ENDOVASCULAR TREATMENTS AND MORE HOT AND CONTROVERSIAL CAROTID TOPICS
SESSION 83:	NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE
PROGRAM L (SESSIONS 84-91 - NEW DEVELOPMENTS IN THE TREATMENT OF POPLITEAL DISEASE: ANEURYSMS, ENTRAPMENT AND OCCLUSIVE LESIONS; ADVANCES IN TREATING ARTERIAL AND GRAFT INFECTIONS; ADVANCES IN VASCULAR IMAGING AND GUIDANCE; AUGMENTED REALITY AND ARTIFICIAL INTELLIGENCE; RECORDED LIVE COMPLEX ENDOVASCULAR CASES FROM MÜNSTER, GERMANY; NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME MANAGEMENT; ADVANCES IN MEDICAL, DRUG, ANTICOAGULANT AND RARE VASCULAR DISEASE TREATMENT; AND ADVANCES IN THE TREATMENT OF VASCULAR TRAUMA; 7:00 A.M. to 5:42 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 84:	POPLITEAL DISEASE TOPICS RELATED TO NEW GUIDELINES, ANEURYSM TREATMENT (PRIMARY AND REDO), ENTRAPMENTS AND ATHERECTOMY FOR OCCLUSIVE LESIONS
SESSION 85:	NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
SESSION 86:	PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
SESSION 87:	AUGMENTED REALITY (AR), MIXED REALITY AND ARTIFICIAL INTELLIGENCE (AI): HOW WILL THEY IMPROVE VASCULAR IMAGING AND ENDOVASCULAR DEVICE GUIDANCE WHILE MINIMIZING RADIATION
SESSION 88:	TWO PRESENTATIONS AND CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY
SESSION 89:	NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
SESSION 90:	NEW DEVELOPMENTS IN MEDICAL AND DRUG TREATMENTS: BEST ANTIPLATELET REGIMENS; UPDATE ON RARE VASCULAR DISEASES
SESSION 91:	ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
PROGRAM M (SESSIONS 92-101 - DEEP VENOUS DISEASE; 6:30 A.M. to 4:57 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 92:	VENOUS IMAGING, CHRONIC VENOUS OBSTRUCTION, PELVIC VENOUS DISORDERS
SESSION 93:	FEMORO-ILIOCAVAL INTERVENTIONAL STRATEGIES TO REDUCE VENOUS HYPERTENSION
SESSION 94:	HYBRID TECHNIQUES AND STENT PROBLEMS POST-IMPLANTATION
SESSION 95:	WOUNDS AND NEW HORIZONS
SESSION 96:	VENOUS STENT TRIALS AND CONCEPTS
SESSION 97:	MORE ILIOFEMORAL FLOW, PELVIC, AND SITE OF SERVICE ISSUES
SESSION 98:	STRATEGIES FOR THROMBOEMBOLIC EVENTS AND VENOUS ANEURYSMS
SESSION 99:	COVID-19; VENOUS THROMBOSIS
SESSION 100:	MORE VENOUS THROMBOSIS STRATEGIES
SESSION 101:	DEEP VEIN VALVE TECHNOLOGIES; MANAGEMENT OF IVC FILTER PROBLEMS AND TUMORS; WHEN ILIAC VEIN STENTING PLUS SUPERFICIAL ABLATION; TREATMENT OF SUPERIOR VENA CAVA SYNDROME

Saturday, November 19, 2022 - Program Details

Open All Saturday Sessions

6:00 AM - General Registration - New York Hilton Midtown
                 Gramercy Suite East, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Grand Ballroom Foyer - 3rd Floor

PROGRAMS N AND O ARE CONCURRENT SATURDAY PROGRAMS
PROGRAM N (SESSIONS 102-106 - TOPICS TOO IMPORTANT TO MISS IN THE TREATMENT OF LOWER EXTREMITY, AORTIC OR CAROTID DISEASE; 6:55 A.M. to 1:30 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 102:	LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
SESSION 103:	MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
SESSION 104:	NEW DEVELOPMENTS IN COVID-19 TREATMENTS AND THE EFFECTS OF COVID-19 ON THE VASCULAR SYSTEM AND MISCELLANEOUS TOPICS INCLUDING TRAINING ISSUES, THE VALUE OF COMBINED VASCULAR AND CARDIAC SURGERY RESIDENCIES AND MORE CAROTID TOPICS
SESSION 105:	AORTIC TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS) AND SPINE EXPOSURE (7- MINUTE TALKS)
SESSION 106:	AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS (4 ¾-MINUTE TALKS)
PROGRAM O (SESSIONS 107-112 - IMPROVING OUTCOMES IN HEMODIALYSIS ACCESS; 8:00 A.M. to 4:05 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 107:	IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 108:	MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 109:	MINISYMPOSIUM ON PREVENTION AND MANAGEMENT OF DIALYSIS ACCESS STEAL SYNDROME
SESSION 110:	POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 111:	NEW TECHNOLOGIES FOR AV ACCESS CREATION (7-MINUTE TALKS)
SESSION 112:	UPDATE ON CLINICAL CHALLENGES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)